𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis

✍ Scribed by Merry L. Tetef; Kim A. Margolin; James H. Doroshow; Steven Akman; Lucille A. Leong; Robert J. Morgan Jr.; James W. Raschko; Neil Slatkin; George Somlo; Jeffrey A. Longmate; Mary I. Carroll; Edward M. Newman

Publisher
Springer
Year
2000
Tongue
English
Weight
121 KB
Volume
46
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Long-term survival of a patient with lep
Long-term survival of a patient with leptomeningeal involvement by nasopharyngeal carcinoma after treatment with high-dose intravenous methotrexate
✍ Carole Fakhry; Gopal Bajaj; Nafi Aygun; William Westra; Maura Gillison πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 672 KB

## Abstract ## Background. Nasopharyngeal carcinoma with leptomeningeal involvement is rare and typically has poor prognosis. ## Methods and Results. We present a case report of a patient with nasopharyngeal carcinoma who was treated with high‐dose intravenous methotrexate and remains asymptomat

Pharmacokinetic modeling of plasma and c
Pharmacokinetic modeling of plasma and cerebrospinal fluid methotrexate after high-dose intravenous infusion in children
✍ E. Chatelut; H. Roche; Y. Plusquellec; F. Peyrille; J. De Biasi; A. Pujol; P. Ca πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 436 KB

A pharmacokinetic study was performed in plasma and cerebrospinal fluid (CSF) of patients suffering from brain tumors to describe the disposition of methotrexate. An open three-compartment model was developed to fit together the data obtained in plasma and CSF. The pharmacokinetic parameters obtaine